Quantinuum (NASDAQ:QNT) Given New $65.00 Price Target at Jefferies Financial Group

Quantinuum (NASDAQ:QNT – Free Report) had its target price reduced by Jefferies Financial Group from $85.00 to $65.00 in a research report report published on Friday,Benzinga reports. They currently have a buy rating on the stock.

Several other research analysts have also weighed in on QNT. Weiss Ratings assumed coverage on Quantinuum in a research report on Monday, August 31st. They issued a “sell (d)” rating on the stock. Rosenblatt Securities reissued a “buy” rating and set a $155.00 price target on shares of Quantinuum in a research report on Thursday, October 22nd. JPMorgan Chase & Co. dropped their price target on Quantinuum from $97.00 to $80.00 and set an “overweight” rating for the company in a research note on Friday. Sanford C. Bernstein restated a “hold” rating on shares of Quantinuum in a report on Wednesday, August 12th. Finally, Needham & Company LLC reduced their price objective on Quantinuum from $100.00 to $60.00 and set a “buy” rating on the stock in a research note on Friday. Thirteen research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Quantinuum currently has an average rating of “Moderate Buy” and an average price target of $85.62.

Get Our Latest Stock Analysis on Quantinuum

Quantinuum Stock Performance

NASDAQ:QNT traded up $7.75 during mid-day trading on Friday, reaching $37.57. The company’s stock had a trading volume of 5,036,156 shares, compared to its average volume of 2,182,406. The company has a market cap of $9.89 billion and a PE ratio of -134.18. The stock’s fifty day moving average price is $43.41. Quantinuum has a twelve month low of $28.31 and a twelve month high of $86.79.

Quantinuum (NASDAQ:QNT – Get Free Report) last released its earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.99) by $0.70. The company had revenue of $9.05 million during the quarter. On average, equities analysts predict that Quantinuum will post -4.76 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Quantinuum

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Russell Investments Group Ltd. acquired a new position in Quantinuum in the 3rd quarter worth $97,000. Pier 88 Investment Partners LLC acquired a new position in shares of Quantinuum in the third quarter worth about $154,000. Fifth Third Bancorp boosted its holdings in Quantinuum by 1,530.2% in the third quarter. Fifth Third Bancorp now owns 1,027 shares of the company’s stock valued at $49,000 after purchasing an additional 964 shares during the last quarter. State of Wyoming purchased a new position in Quantinuum in the third quarter valued at about $378,000. Finally, Flagship Harbor Advisors LLC purchased a new stake in Quantinuum during the 3rd quarter worth approximately $206,000.

Quantinuum News Summary

Here are the key news stories impacting Quantinuum this week:

  • Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
  • Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
  • Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
  • Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

Quantinuum Company Profile

(Get Free Report)

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum’s software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

Further Reading

Analyst Recommendations for Quantinuum (NASDAQ:QNT)

Receive News & Ratings for Quantinuum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantinuum and related companies with MarketBeat.com's FREE daily email newsletter.